Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Retinoblastoma × Lasers × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 1 Retinal Neoplasms 1 Neoplasms 1 Keratosis, Actinic 1 Eye Neoplasms 1

Interventions

Carboplatin 12 Etoposide 10 Vincristine 9 Filgrastim 7 Melphalan 5 Cyclophosphamide 5 Topotecan 4 Thiotepa 4 Cryotherapy 3 Temozolomide 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Mesna 2 Granulocyte Colony-Stimulating Factor 2 Drug Therapy 2 Doxorubicin 2 Cisplatin 2 trioctyl phosphine oxide 1 pegfilgrastim 1 cixutumumab 1 becatecarin 1 abemaciclib 1 Specimen Handling 1 Ranibizumab 1 Proton Therapy 1 Platinum Compounds 1 Observation 1 Microscopy, Acoustic 1 Methotrexate 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02866136 2025-11-24

RETINO2011

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma, Retinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡